We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Intuitive Surgical and InTouch Health Form Partnership
Read MoreHide Full Article
Intuitive Surgical Inc. (ISRG - Free Report) recently inked a strategic partnership with telehealth network and managed services provider – InTouch Health. Under the terms of the agreement, the da-Vinci maker will not only invest in InTouch but will also jointly develop patient informatics solutions for surgical systems.
The investment will definitely help InTouch enhance the functionality and scale of its telehealth cloud. Jointly, the companies will focus on developing products, which include solutions that will deliver data to surgeons in the form of 3D reconstructions of anatomical structures.
Such innovative solutions will improve the work-flow of a surgeon, using the da-Vinci surgical system. We also believe the availability of this surgeon-friendly application along with da-Vinci will drive faster adoption of the system, thereby boosting procedural growth.
Notably, worldwide da Vinci procedure volumes rose approximately 17% year over year to 176K in the first quarter of 2016. Procedures in the U.S. grew approximately 15%, while that outside the U.S. increased about 22%.
Intuitive Surgical forecasts 2016 procedural volumes in the range of 12% to 14%, up from the earlier guided range of 9% to 12%.
Intuitive Surgical continues to focus on developing new products that enhance the capabilities of the da-Vinci system. During the first quarter of 2016, the company launched intra-operative Table Motion that received strong customer feedback on its utility, particularly in general surgery.
Intuitive Surgical also launched 30-millimeter Xi stapler designed to facilitate stapling in thoracic procedures and Xi Single-Site instrument and accessory kit during the quarter.
We believe incremental spending on product development and higher investment on expanding the company’s footprint in international markets (particularly in Europe) are prudent moves that will drive growth.
Zacks Rank & Key Picks
Currently, Intuitive Surgical carries a Zacks Rank #3 (Hold).
Better-ranked medical instrument stocks include CryoLife , IRadimed (IRMD - Free Report) and Masimo Corp (MASI - Free Report) . All the three stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Intuitive Surgical and InTouch Health Form Partnership
Intuitive Surgical Inc. (ISRG - Free Report) recently inked a strategic partnership with telehealth network and managed services provider – InTouch Health. Under the terms of the agreement, the da-Vinci maker will not only invest in InTouch but will also jointly develop patient informatics solutions for surgical systems.
The investment will definitely help InTouch enhance the functionality and scale of its telehealth cloud. Jointly, the companies will focus on developing products, which include solutions that will deliver data to surgeons in the form of 3D reconstructions of anatomical structures.
Such innovative solutions will improve the work-flow of a surgeon, using the da-Vinci surgical system. We also believe the availability of this surgeon-friendly application along with da-Vinci will drive faster adoption of the system, thereby boosting procedural growth.
Notably, worldwide da Vinci procedure volumes rose approximately 17% year over year to 176K in the first quarter of 2016. Procedures in the U.S. grew approximately 15%, while that outside the U.S. increased about 22%.
Intuitive Surgical forecasts 2016 procedural volumes in the range of 12% to 14%, up from the earlier guided range of 9% to 12%.
INTUITIVE SURG Price
INTUITIVE SURG Price | INTUITIVE SURG Quote
Intuitive Surgical continues to focus on developing new products that enhance the capabilities of the da-Vinci system. During the first quarter of 2016, the company launched intra-operative Table Motion that received strong customer feedback on its utility, particularly in general surgery.
Intuitive Surgical also launched 30-millimeter Xi stapler designed to facilitate stapling in thoracic procedures and Xi Single-Site instrument and accessory kit during the quarter.
We believe incremental spending on product development and higher investment on expanding the company’s footprint in international markets (particularly in Europe) are prudent moves that will drive growth.
Zacks Rank & Key Picks
Currently, Intuitive Surgical carries a Zacks Rank #3 (Hold).
Better-ranked medical instrument stocks include CryoLife , IRadimed (IRMD - Free Report) and Masimo Corp (MASI - Free Report) . All the three stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>